1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Transplant Type
5.1 Introduction
5.2 Allogeneic
5.3 Autologous
5.4 Other Transplant Types
6 Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Disease Indication
6.1 Introduction
6.2 Lymphoproliferative Disorders
6.2.1 Hodgkin lymphoma
6.2.2 Plasma Cell Disorders
6.2.3 Other Lymphoproliferative Disorders
6.3 Non-malignant Disorders
6.3.1 Bone Marrow Failure
6.3.2 Hemoglobinopathies
6.3.3 Autoimmune Disease
6.3.4 Others Non-malignant Disorders
6.4 Leukemia
6.4.1 Acute Lymphatic Leukemia
6.4.2 Acute Myeloid Leukemia
6.4.3 Myelodysplastic Syndrome (MDS)
6.4.4 Other Leukemia
6.5 Other Disease Indications
7 Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application
7.1 Introduction
7.2 Bone Marrow Transplant (BMT)
7.3 Peripheral Blood Stem Cells Transplant (PBSCT)
7.4 Cord Blood Transplant (CBT)
7.5 Other Applications
8 Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Specialty Clinics
8.4 Other End Users
9 Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 AllCells Corp.
11.2 Athersys Inc.
11.3 Beike Biotechnology Co. Ltd.
11.4 bluebird bio Inc.
11.5 Cellular Biomedicine Group Inc.
11.6 Gamida Cell Ltd.
11.7 Lonza Group Ltd.
11.8 MEDIPOST Co. Ltd.
11.9 Merck KGaA
11.10 Mesoblast Ltd.
11.11 Pluristem Therapeutics Inc.
11.12 Sanofi SA
11.13 Sartorius CellGenix GmbH
11.14 ScienCell Research Laboratories, Inc.
11.15 STEMCELL Technologies, Inc.
11.16 Taiga Biotechnologies Inc.
11.17 Takeda Pharmaceutical Co. Ltd.
11.18 Talaris Therapeutics
11.19 Thermo Fisher Scientific
List of Tables
Table 1 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Transplant Type (2021-2030) ($MN)
Table 3 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Allogeneic (2021-2030) ($MN)
Table 4 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Autologous (2021-2030) ($MN)
Table 5 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Other Transplant Types (2021-2030) ($MN)
Table 6 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Disease Indication (2021-2030) ($MN)
Table 7 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Lymphoproliferative Disorders (2021-2030) ($MN)
Table 8 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Hodgkin lymphoma (2021-2030) ($MN)
Table 9 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Plasma Cell Disorders (2021-2030) ($MN)
Table 10 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Other Lymphoproliferative Disorders (2021-2030) ($MN)
Table 11 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Non-malignant Disorders (2021-2030) ($MN)
Table 12 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Bone Marrow Failure (2021-2030) ($MN)
Table 13 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Hemoglobinopathies (2021-2030) ($MN)
Table 14 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Autoimmune Disease (2021-2030) ($MN)
Table 15 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Others Non-malignant Disorders (2021-2030) ($MN)
Table 16 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Leukemia (2021-2030) ($MN)
Table 17 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Acute Lymphatic Leukemia (2021-2030) ($MN)
Table 18 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Acute Myeloid Leukemia (2021-2030) ($MN)
Table 19 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Myelodysplastic Syndrome (MDS) (2021-2030) ($MN)
Table 20 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Other Leukemia (2021-2030) ($MN)
Table 21 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Other Disease Indications (2021-2030) ($MN)
Table 22 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Application (2021-2030) ($MN)
Table 23 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Bone Marrow Transplant (BMT) (2021-2030) ($MN)
Table 24 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Peripheral Blood Stem Cells Transplant (PBSCT) (2021-2030) ($MN)
Table 25 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Cord Blood Transplant (CBT) (2021-2030) ($MN)
Table 26 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Other Applications (2021-2030) ($MN)
Table 27 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By End User (2021-2030) ($MN)
Table 28 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Hospitals (2021-2030) ($MN)
Table 29 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Specialty Clinics (2021-2030) ($MN)
Table 30 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
